BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11207249)

  • 1. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors.
    Hanke T; Raulet DH
    J Immunol; 2001 Mar; 166(5):3002-7. PubMed ID: 11207249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
    Fahlén L; Lendahl U; Sentman CL
    J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development.
    Lowin-Kropf B; Held W
    J Immunol; 2000 Jul; 165(1):91-5. PubMed ID: 10861039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
    Michaëlsson J; Achour A; Rölle A; Kärre K
    J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.
    Hanke T; Takizawa H; McMahon CW; Busch DH; Pamer EG; Miller JD; Altman JD; Liu Y; Cado D; Lemonnier FA; Bjorkman PJ; Raulet DH
    Immunity; 1999 Jul; 11(1):67-77. PubMed ID: 10435580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice.
    Salcedo M; Diehl AD; Olsson-Alheim MY; Sundbäck J; Van Kaer L; Kärre K; Ljunggren HG
    J Immunol; 1997 Apr; 158(7):3174-80. PubMed ID: 9120271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of Ly49A on T cells impairs a specific antitumor response.
    Brawand P; Lemonnier FA; MacDonald HR; Cerottini JC; Held W
    J Immunol; 2000 Aug; 165(4):1871-6. PubMed ID: 10925266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killing of MHC class I(-) lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors.
    Lindberg J; Martín-Fontecha A; Höglund P
    Int Immunol; 1999 Aug; 11(8):1239-46. PubMed ID: 10421781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
    Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
    J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
    Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
    Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro.
    Kambayashi T; Michaëlsson J; Fahlén L; Chambers BJ; Sentman CL; Kärre K; Ljunggren HG
    Eur J Immunol; 2001 Mar; 31(3):869-75. PubMed ID: 11241292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.
    Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
    J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.
    Roth C; Carlyle JR; Takizawa H; Raulet DH
    Immunity; 2000 Jul; 13(1):143-53. PubMed ID: 10933402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing self-recognition by Ly49A NK cells.
    Ioannidis V; Zimmer J; Beermann F; Held W
    J Immunol; 2001 Dec; 167(11):6256-62. PubMed ID: 11714788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model.
    Hanke T; Takizawa H; Raulet DH
    Eur J Immunol; 2001 Nov; 31(11):3370-9. PubMed ID: 11745355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.